Annual SG&A:
$70.45M+$32.81M(+87.19%)Summary
- As of today, NAMS annual SG&A is $70.45 million, with the most recent change of +$32.81 million (+87.19%) on December 31, 2024.
- During the last 3 years, NAMS annual SG&A has risen by +$64.77 million (+1140.90%).
- NAMS annual SG&A is now at all-time high.
Performance
NAMS SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$27.15M(-100.00%)Summary
- As of today, NAMS quarterly SG&A is $0.00, with the most recent change of -$27.15 million (-100.00%) on June 30, 2025.
- Over the past year, NAMS quarterly SG&A has stayed the same.
- NAMS quarterly SG&A is now -100.00% below its all-time high of $27.15 million, reached on March 31, 2025.
Performance
NAMS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$2.24B-$165.72M(-7.99%)Summary
- As of today, NAMS TTM SG&A is -$2.24 billion, with the most recent change of -$165.72 million (-7.99%) on June 30, 2025.
- Over the past year, NAMS TTM SG&A has dropped by -$2.24 billion (-100.00%).
- NAMS TTM SG&A is now -50277.64% below its all-time high of $4.46 million.
Performance
NAMS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
NAMS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +87.2% | 0.0% | -100.0% |
| 3Y3 Years | +1140.9% | 0.0% | -100.0% |
| 5Y5 Years | +4549.0% | 0.0% | -100.0% |
NAMS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +1140.9% | -100.0% | at low | -7570.1% | at low |
| 5Y | 5-Year | at high | +4549.0% | -100.0% | at low | >-9999.0% | at low |
| All-Time | All-Time | at high | +4549.0% | -100.0% | at low | >-9999.0% | at low |
NAMS Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $27.15M(0.0%) |
| Mar 2025 | - | $27.15M(>+9900.0%) | $27.15M(>+9900.0%) |
| Dec 2024 | $70.45M(+87.2%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2023 | $37.63M(+92.9%) | - | - |
| Mar 2023 | - | $6.84M | $6.84M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $19.51M(+243.6%) | - | - |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | $5.68M(+274.6%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $1.52M | $0.00 | $0.00 |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual SG&A?
- What is the all-time high annual SG&A for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual SG&A year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly SG&A?
- What is the all-time high quarterly SG&A for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly SG&A year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM SG&A?
- What is the all-time high TTM SG&A for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM SG&A year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual SG&A?
The current annual SG&A of NAMS is $70.45M
What is the all-time high annual SG&A for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual SG&A is $70.45M
What is NewAmsterdam Pharma Company N.V. annual SG&A year-on-year change?
Over the past year, NAMS annual SG&A has changed by +$32.81M (+87.19%)
What is NewAmsterdam Pharma Company N.V. quarterly SG&A?
The current quarterly SG&A of NAMS is $0.00
What is the all-time high quarterly SG&A for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly SG&A is $27.15M
What is NewAmsterdam Pharma Company N.V. quarterly SG&A year-on-year change?
Over the past year, NAMS quarterly SG&A has changed by $0.00 (0.00%)
What is NewAmsterdam Pharma Company N.V. TTM SG&A?
The current TTM SG&A of NAMS is -$2.24B
What is the all-time high TTM SG&A for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM SG&A is $4.46M
What is NewAmsterdam Pharma Company N.V. TTM SG&A year-on-year change?
Over the past year, NAMS TTM SG&A has changed by -$2.24B (-100.00%)